Takara Bio Operating Income Over Time
| TF2 Stock | EUR 6.05 0.05 0.82% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Takara Bio Performance and Takara Bio Correlation. Takara |
Cross Equities Operating Income Analysis
Compare Takara Bio and related stocks such as Hitachi Construction, PACIFIC ONLINE, and AUST AGRICULTURAL Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCM | 69.2 B | 69.2 B | 69.2 B | 69.2 B | 64.1 B | 44.1 B | 23.6 B | 95.7 B | 102.3 B | 72.8 B | 28.2 B | 106.6 B | 133.3 B | 162.7 B | 154.7 B | 177.9 B | 96.9 B |
| 4P7 | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 167.4 M | 126.3 M | 171.3 M | 210.3 M | 235.4 M | 47.8 M | 21.1 M | (14.1 M) | 61.4 M | 55.3 M | 91.3 M |
| AY5 | (187.2 M) | (187.2 M) | (187.2 M) | (187.2 M) | (187.2 M) | (187.2 M) | (187.2 M) | (55.5 M) | (196.6 M) | 58.1 M | 71 M | 203.3 M | 13.1 M | (120.4 M) | 14.8 M | 17 M | 17.8 M |
| XC5 | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 254.7 M | 130.3 M | 265.9 M | 309.7 M | 356.1 M | 264.1 M |
| HNC | 199.6 M | 199.6 M | 199.6 M | 199.6 M | 199.6 M | 199.6 M | 199.6 M | 73.5 M | (40.2 M) | (85.5 M) | (58.2 M) | (63.7 M) | (18.1 M) | 2.4 M | 16.1 M | 14.5 M | 15.2 M |
| UAO | (5.2 M) | (5.2 M) | (5.2 M) | (5.2 M) | (5.2 M) | (15.9 M) | (4.7 M) | 26.2 M | 42.6 M | 42.1 M | 95.9 M | 111.2 M | 160.7 M | 206.7 M | 265 M | 304.8 M | 320 M |
| BOQ | 706 K | 706 K | 706 K | 706 K | 706 K | 706 K | 706 K | 1.1 M | 1.2 M | 339 K | 376 K | 517 K | 1.9 M | 2.5 M | 2.6 M | 3 M | 3.2 M |
Takara Bio and related stocks such as Hitachi Construction, PACIFIC ONLINE, and AUST AGRICULTURAL Operating Income description
Operating Income is the amount of profit realized from Takara Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Takara Bio is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Takara Bio | TF2 |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 7-4-38 Nojihigashi, Kusatsu, |
| Exchange | Frankfurt Exchange |
EUR 6.05
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.